Zika Vaccines Market
Zika Vaccines Market Scope: Industry
Analysis, Market Size, Growth, Trends till 2030
Download Zika Vaccines Market Report
Zika
Vaccine Market Size and Growth
The Zika virus vaccine market is expected to grow at a compound annual growth rate (CAGR) of 5.3–5.4% from 2023–2031, reaching a value of $24.53–$26.26 billion. The market growth of Zika vaccines is influenced by various factors, including ongoing research and development efforts, clinical trial outcomes, regulatory approvals, and market dynamics. Ongoing advancements in vaccine technologies, such as mRNA and viral vector platforms, may contribute to the development of more effective Zika vaccines.
Companies Covered : (Covid-19 Impact Covered)
o Sanofi Pasteur
o Takeda Pharmaceuticals
o Moderna
o Inovio Pharmaceuticals
o Bharat Biotech
o GlaxoSmithKline
A major player in the vaccine industry, Sanofi has been heavily involved in the development of Zika vaccines. An Indian company, Bharat Biotech has produced Zika vaccine candidates in collaboration with the government. Innovations in vaccine technology, such as mRNA and DNA-based vaccines, are likely to transform this market, making vaccines more effective and widely available. Future projections suggest continued market expansion as public awareness and global vaccination efforts ramp up to prevent the spread of the Zika virus.
Zika Vaccine Market Segmentation
By Application
✓ Hospitals and Clinics
✓ Research Institutes
✓ Government
Immunization Programs
By Product
• DNA-based Vaccines
• Inactivated Virus Vaccines
• mRNA Vaccines
• Live Attenuated Vaccines
Zika Vaccine Market Growth 2024-2030
$ X Billion USD
Market Size (USD)
